+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Contrast Media Injectors Market to 2027 - Country Analysis and Forecasts By Product; by Application; and Geography

  • ID: 4769894
  • Report
  • Region: United States
  • 89 pages
  • The Insight Partners
1 of 3

FEATURED COMPANIES

  • AngioDynamics
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Cook Medical Incorporated
  • General Electric
  • MORE
The US contrast media injectors market is expected to reach US$ 350.4 Mn in 2027 from US$ 183.8 Mn in 2018. The market is estimated to grow with a CAGR of 7.5% from 2019-2027.

The growth of the contrast media injectors market is primarily attributed to the increasing number of patients suffering with chronic diseases. However, side effects associated with the contrast media agents is likely to hinder the growth of the market during the forecast period. Additionally, other factors such as increasing number of approvals for contrast agents as well as robust pipeline products are contributed to the growth of the US contrast media injectors market. US has a marginal number of companies headquartered and operating in the contrast media injectors market. The major manufacturing companies through their diversified portfolio that commercializes imaging agents and products also work evidently on the development of new agents and injector systems that are likely to enhance the efficiency of current imaging modalities, thereby bringing in new technologies and innovations in the market would be responsible to maintain the dominance of the country.

For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway. Thus, similar potential products that are beneficial from the commercial as well as therapeutic and diagnostic perspectives is expected to create opportunistic scenario for the growth of the contrast media injectors market in the coming years.

In 2018, the consumables segment held a largest market share of 63.0% of the contrast media injectors market, by product. This segment is also expected to dominate the market in 2027 since the consumables generally used are meant for single use and hence are replaced after the completion of every process. Moreover, the consumables segment is anticipated to witness the significant growth rate of 7.7% during the forecast period, 2019 to 2027.

US contrast media injectors market by application was led by the radiology segment. The segment has largest market share in 2018, which accounted 47.3% and is expected to dominate the market in 2027. However, the interventional cardiology segment is expected to witness growth at a significant rate of 8.5% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for contrast media injectors included in the report are Centers of Disease Control & Prevention, Food and Drug Administration, World Health Organization and Others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AngioDynamics
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Cook Medical Incorporated
  • General Electric
  • MORE
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 US Contrast Media Injectors Market - By Product
1.3.2 US Contrast Media Injectors Market - By Application

2. US CONTRAST MEDIA INJECTORS MARKET - KEY TAKEAWAYS

3. RESEARCH METHODOLOGY
3.1 COVERAGE
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH

4. US CONTRAST MEDIA INJECTORS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 US - PEST Analysis

5. US CONTRAST MEDIA INJECTORS MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Increasing Number of Approvals for Contrast Agents
5.1.2 Increasing Number of Patients Suffering with Chronic Diseases
5.2 KEY MARKET RESTRAINTS
5.2.1 Side Effects Associated with the Contrast Media Agents
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Robust Pipeline Products
5.4 FUTURE TRENDS
5.4.1 Increasing Adoption of Syringe-less Power Injectors
5.5 IMPACT ANALYSIS

6. CONTRAST MEDIA INJECTORS MARKET - US ANALYSIS
6.1 US CONTRAST MEDIA INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 EXPERT OPINIONS

7. US CONTRAST MEDIA INJECTORS MARKET ANALYSIS- BY PRODUCT
7.1 OVERVIEW
7.2 US CONTRAST MEDIA INJECTORS MARKET BY PRODUCT, 2018 & 2027 (%)
7.3 INJECTOR SYSTEMS MARKET
7.3.1 Overview
7.3.2 US Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 MRI Injector Systems Market
7.3.3.1 Overview
7.3.3.2 US MRI Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 CT Injector Systems Market
7.3.4.1 Overview
7.3.4.2 US CT Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Angiography Injector Systems Market
7.3.5.1 Overview
7.3.5.2 US Angiography Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 CONSUMABLES MARKET
7.4.1 Overview
7.4.2 US Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Injector Heads Market
7.4.3.1 Overview
7.4.3.2 US Injector Heads Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3.3 Single Head Injectors Market
7.4.3.3.1 Overview
7.4.3.3.2 US Single Head Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3.4 Dual Head Injectors Market
7.4.3.4.1 Overview
7.4.3.4.2 US Dual Head Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3.5 Syringeless Injectors Market
7.4.3.5.1 Overview
7.4.3.5.2 US Syringeless Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Tubing Market
7.4.4.1 Overview
7.4.4.2 US Tubing Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Syringes Market
7.4.5.1 Overview
7.4.5.2 US Syringes Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.6 Other Consumables Market
7.4.6.1 Overview
7.4.6.2 US Other Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 ACCESSORIES MARKET
7.5.1 Overview
7.5.2 US Accessories Market Revenue and Forecasts to 2027 (US$ Mn)

8. US CONTRAST MEDIA INJECTORS MARKET ANALYSIS- BY APPLICATION
8.1 OVERVIEW
8.2 US CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION 2018 & 2027 (%)
8.3 INTERVENTIONAL CARDIOLOGY MARKET
8.3.1 Overview
8.3.2 US Interventional Cardiology Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 INTERVENTIONAL RADIOLOGY MARKET
8.4.1 Overview
8.4.2 US Interventional Radiology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 RADIOLOGY MARKET
8.5.1 Overview
8.5.2 US Radiology Market Revenue and Forecasts to 2027 (US$ Mn)

9. CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 - US ANALYSIS
9.1 US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.1.1 US Contrast Media Injectors Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.1.1 US Injector Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.1.2 US Injector Systems Market Volume And Forecasts to 2027, By Type (Units)
9.1.1.3 US Consumables Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.1.3.1 US Injector Heads Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.2 US Contrast Media Injectors Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. CONTRAST AGENT INJECTORS MARKET - INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 COMPARATIVE COMPANY ANALYSIS
10.3 GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%)
10.4 ORGANIC DEVELOPMENTS
10.4.1 Overview
10.5 INORGANIC DEVELOPMENTS
10.5.1 Overview

11. CONTRAST MEDIA INJECTORS MARKET-KEY COMPANY PROFILES
11.1 BAYER AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 NEMOTO KYORINDO CO., LTD.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 SHENZHEN XINGUAN ELECTROMECHANICAL CO. LTD.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GENERAL ELECTRIC
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 ANGIODYNAMICS
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ULRICH GMBH & CO.KG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 APOLLO RT CO. LTD.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 BRACCO IMAGING S.P.A.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 GUERBET GROUP
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 COOK MEDICAL INCORPORATED
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product portfolio
11.10.5 SWOT ANALYSIS
11.10.6 KEY DEVELOPMENTS
11.11 SMITHS MEDICAL
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 BOSTON SCIENTIFIC CORPORATION
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments

12. APPENDIX
12.1 ABOUT THE PUBLISHER
12.2 GLOSSARY OF TERMS

LIST OF TABLES
TABLE 1. US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 2. US INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 3. US INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (UNITS)
TABLE 4. US CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. US INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 6. US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 7. ORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 8. INORGANIC DEVELOPMENTS DONE BY COMPANIES
TABLE 9. GLOSSARY OF TERMS, CONTRAST MEDIA INJECTORS MARKET

LIST OF FIGURES
FIGURE 1. CONTRAST MEDIA INJECTORS MARKET SEGMENTATION
FIGURE 2. US CONTRAST MEDIA INJECTORS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. US CONTRAST MEDIA INJECTORS MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 4. US PEST ANALYSIS
FIGURE 5. US CONTRAST MEDIA INJECTORS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS
FIGURE 6. US CONTRAST MEDIA INJECTORS MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027
FIGURE 7. US CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 2018 & 2027 (%)
FIGURE 8. US INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 9. US MRI INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 10. US CT INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 11. US ANGIOGRAPHY INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 12. US CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 13. US INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 14. US SINGLE HEAD INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 15. US DUAL HEAD INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. US SYRINGELESS INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. US TUBING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. US SYRINGES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. US OTHER CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. US ACCESSORIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. US CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION 2018 & 2027 (%)
FIGURE 22. US INTERVENTIONAL CARDIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. US INTERVENTIONAL RADIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 24. US RADIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. COMPARATIVE COMPANY ANALYSIS
FIGURE 26. GROWTH STRATEGIES DONE BY THE COMPANIES IN THE MARKET, (%)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Boston Scientific Corporation
  • Shenzhen Xinguan Electromechanical Co. Ltd.
  • ulrich GmbH & Co.KG
  • APOLLO RT Co. Ltd.
  • Bracco Imaging S.p.A.
  • Guerbet SA
  • Cook Medical Incorporated
  • Smiths Medical
  • Sino Medical-Device Technology Co., Ltd.
  • Bayer AG
  • Nemoto Kyorindo Co., Ltd
  • General Electric
  • AngioDynamics
Note: Product cover images may vary from those shown
Adroll
adroll